Peoples Bank (Kansas)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,983
Closed -$121K 142
2025
Q1
$121K Hold
1,983
0.08% 125
2024
Q4
$112K Hold
1,983
0.08% 123
2024
Q3
$103K Hold
1,983
0.07% 131
2024
Q2
$82.3K Hold
1,983
0.06% 124
2024
Q1
$108K Hold
1,983
0.08% 109
2023
Q4
$102K Buy
1,983
+50
+3% +$2.63K 0.08% 118
2023
Q3
$112K Buy
+1,933
New +$118K 0.1% 113

Other funds holding BMY

Peoples Bank (Kansas)'s BMY Position: Q2 2025 in Review

Peoples Bank (Kansas) sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 1,983 shares — an estimated $121K sold.

Peoples Bank (Kansas) first reported a position in BMY in Q3 2023 and held it in 7 quarters. The position peaked at $121K in Q1 2025. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Peoples Bank (Kansas) reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Peoples Bank (Kansas) sold 1,983 Bristol-Myers Squibb shares in Q2 2025, an estimated $121K.
  • Peoples Bank (Kansas) first reported a position in Bristol-Myers Squibb in Q3 2023 and held it in 7 quarters.
  • Peoples Bank (Kansas)'s Bristol-Myers Squibb position peaked at $121K in Q1 2025.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2025, filed 10 Jul 2025.